Compounds > fenofibrate

fenofibrate and 20-hydroxy-5,8,11,14-eicosatetraenoic acid

fenofibrate has been researched along with 20-hydroxy-5,8,11,14-eicosatetraenoic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bohman, Q; Flasch, A; Roman, RJ; Stec, DE; Taylor, M; Vera, T1
Capdevila, JH; Falck, JR; Lavrentyev, EN; Malik, KU; Parmentier, JH1
Chen, YJ; Li, J; Quilley, J1
Althurwi, HN; El-Kadi, AO; Elshenawy, OH1
Čertíková Chábová, V; Červenka, L; Doleželová, Š; Jíchová, Š; Kompanowska-Jezierska, E; Kopkan, L; Maxová, H; Sadowski, J; Sporková, A; Vaňourková, Z1

Other Studies

5 other study(ies) available for fenofibrate and 20-hydroxy-5,8,11,14-eicosatetraenoic acid

ArticleYear
Fenofibrate prevents the development of angiotensin II-dependent hypertension in mice.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 45, Issue:4

    Topics: Angiotensin II; Animals; Blood Pressure; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Fenofibrate; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Vasoconstrictor Agents

2005
Evaluation of cytochrome P450 4 family as mediator of phospholipase D activation in aortic vascular smooth muscle cells.
    Life sciences, 2005, Jul-15, Volume: 77, Issue:9

    Topics: Amides; Animals; Aorta; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Down-Regulation; Enzyme Activation; Fenofibrate; Hydroxyeicosatetraenoic Acids; Male; Mixed Function Oxygenases; Muscle, Smooth, Vascular; Norepinephrine; Oligonucleotides, Antisense; Peroxisome Proliferators; Phospholipase D; Pyrimidines; Rabbits; Sulfones

2005
Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:5

    Topics: Aldehyde Reductase; Animals; Antioxidants; Arachidonic Acid; Benzothiazoles; Cyclic N-Oxides; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Enzyme Induction; Enzyme Inhibitors; Fenofibrate; Hydroxyeicosatetraenoic Acids; Hypoglycemic Agents; Indomethacin; Insulin; Kidney; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Perfusion; Phthalazines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Spin Labels; Tyrosine

2008
Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy.
    Journal of cardiovascular pharmacology, 2014, Volume: 63, Issue:2

    Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Cardiomegaly; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Fenofibrate; Gene Expression Regulation, Enzymologic; Hydroxyeicosatetraenoic Acids; Hypolipidemic Agents; Isoproterenol; Male; Rats; Rats, Sprague-Dawley

2014
Fenofibrate Attenuates Hypertension in Goldblatt Hypertensive Rats: Role of 20-Hydroxyeicosatetraenoic Acid in the Nonclipped Kidney.
    The American journal of the medical sciences, 2017, Volume: 353, Issue:6

    Topics: Animals; Fenofibrate; Hydroxyeicosatetraenoic Acids; Hypertension, Renovascular; Hypolipidemic Agents; Kidney; Male; Rats; Rats, Sprague-Dawley

2017